[1]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;MERCK&COINC-WO2006/122200,2006,A1Locationinpatent:Page/Pagecolumn47-48
[1]Patent:WO2006/122200,2006,A1.Locationinpatent:Page/Pagecolumn47
915030-08-9
1076197-53-9
1180526-74-2
1363405-29-1 | 5-Iodo-1,7-naphthyridin-8(7h)-one | AA0011P9 | MFCD21607103
1365272-53-2 | N-[(4-Cyanophenyl)(4-fluorophenyl)methyl]acetamide | AA0011XB | MFCD21609716
13669-28-8 | 1-Methyl-4-methylidenepiperidine | AA00125F | MFCD09834620
13688-68-1 | 9,9-Dimethyl-9h-9-silafluorene | AA0012GB | MFCD00093801
137125-44-1 | Silsesquioxanes, hydrogen, hydroxy-terminated | AA0012RY
1373233-43-2 | N-[(4-Chlorophenyl)(3-fluorophenyl)methyl]acetamide | AA00132K | MFCD22192546
1375069-12-7 | 5-(3,5-Difluorophenyl)-2-methoxypyridine | AA0013CZ | MFCD22205808
137756-90-2 | 4-(2-Bromoethyl)phenylboronic acid | AA0013PY | MFCD12546453
133085-33-3 | [1,1'-Biphenyl]-2-carboxylic acid, 4'-[[2-butyl-6-[[(cyclohexylamino)carbonyl]amino]-1H-benzimidazol-1-yl]methyl]- | AA001461 | MFCD29924788
13331-23-2 | Furan-2-boronic acid | AA0014J3 | MFCD00799544